Meanwhile, thalidomide is a TNFα inhibitor that down-regulating the NFκB-iNOS pathway29, which simultaneously contributes to HPS and muscle wasting in cirrhosis. This evidence concerns the gene TNF and Hermansky-Pudlak syndrome.